HHS Inspector General To Probe CMS' Oversight Of Drug Compounding (Daily News - 02-06-2014)

        

The HHS Office of Inspector General plans to analyze Medicare's oversight of drug compounding done in acute care hospitals and whether Medicare Administrative Contractors appropriately process Part B claims for these products, according to OIG's work plan for fiscal 2014.
quoted from InsideHealthPolicy.com